Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC
  • 8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China
  • 8/8/2025Triple Squeeze Threatens China's Global Drug Push
  • 8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...
  • 8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion
  • 8/8/2025Innogen Launches $87M Hong Kong IPO to Fund Trials and Launches
  • 8/8/2025AlphaGen Closes Series A Funding
  • 8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...
  • 8/8/2025AsiFlyer Secures New Funding to Propel Next‑Gen Botulinum Toxin
  • 8/8/2025AstraZeneca Expands Use of Fasenra in China
  • 8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...
  • 8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
  • 8/6/2025China Urges Price Discipline as Drugmakers Flood Latest VBP Tender
  • 8/6/2025XTalPi Signs US$6 Billion Global Drug Discovery Deal with DoveTree
  • 8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...
  • 8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery
  • 8/6/2025CDE Releases Updated Roster of External Drug Review Experts
  • 8/6/2025China Launches 11th National VBP Round with New Flexibility for Hospit...
  • 8/6/2025China's CGT Boom: NMPA's CDE and Tsinghua Team Publish Eight-Year Revi...
  • 8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
  • 8/6/2025Chinese Private Biopharma Sees Surge in July Financing, Highest Since ...
  • 8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
  • 8/6/2025CDE Solicits Comments on Guidelines for Developing Appropriate Drug Pa...
  • 8/6/2025CDE Seeks Public Comments on Revised Technical Guidelines for Recombin...
  • 8/5/2025Zenitar Raises ~CNY 400M to Accelerate AI-Driven Drug Discovery and O...
  • 8/5/2025EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...
  • 8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...
  • 8/5/2025Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development
  • 8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
  • 8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
  • Page:7/58 Total number of articles:1735: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group